查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1612126

脱髮症治疗药物市场：按疾病类型、给药途径、性别、治疗选择和最终用户 - 全球预测 2025-2030

Alopecia Treatment Market by Disease Type (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), Route of Administration (Injectable, Oral, Topical), Gender, Treatment Option, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年脱髮症治疗药物市场规模为48.5亿美元，预计2024年将达到52.7亿美元，复合年增长率为8.89%，预计到2030年将达到88.1亿美元。

脱髮症治疗市场的范围和定义包括旨在对抗与脱髮症、雄性秃和其他头皮疾病相关的脱髮的治疗性介入和产品。脱髮对人的生活品质和自尊心产生的心理影响强调了这种治疗的必要性。治疗方法包括局部治疗、内服药物、植髮等外科手术以及富含血小板的血浆和雷射疗法等新治疗方法。最终使用领域主要包括皮肤科诊所、美容中心和个人家庭使用者。关键的成长要素包括脱髮症治疗意识的提高、治疗技术的进步以及医疗保健支出的增加。值得注意的是，生技药品的出现和基因治疗研究和开发的活性化正在为市场参与者创造新的机会。潜在的机会在于透过个人化医疗方法和负担得起的解决方案扩大新兴市场的准入。

主要市场统计
基准年[2023] 48.5亿美元
预测年份 [2024] 52.7亿美元
预测年份 [2030] 88.1亿美元
复合年增长率（%） 8.89%

然而，该市场面临一些限制和挑战，包括高昂的治疗成本、不同的患者反应、潜在的副作用和监管障碍。此外，与美容护理相关的文化观念和偏见也会抑制某些地区的成长。为了克服这些挑战并推动成长，创新和研究正在推动开发更安全、更有效、副作用更少的治疗方法，例如基于胜肽的治疗方法和奈米疗法等新的递送机制。了解头髮疾病遗传基础的尖端研究可能会进一步调整治疗方案。市场动态是以竞争压力和快速技术进步为特征的动态市场，这意味着需要持续创新。公司可以透过投资研究合作以及与研究机构和医疗保健提供者建立策略伙伴关係来增强研发能力并扩大产品系列，从而获得竞争优势。

市场动态：快速发展的脱髮症治疗市场的主要市场洞察

供需的动态交互作用正在改变脱髮症药物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 脱髮症和脱髮症的盛行率增加
    • 人们对除毛和植髮的认识不断增强
    • 收入水准上升和医疗保健支出增加
  • 市场限制因素
    • 脱髮症治疗缺乏报销政策
  • 市场机会
    • 新脱髮症治疗方法和药物的出现
    • 增加并扩大对毛髮移植诊所的投资
  • 市场挑战
    • 关于某些脱髮症治疗方法的有效性和副作用的问题

波特的五力：驾驭脱髮症药物市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解脱髮症治疗药物市场的外部影响

外部宏观环境因素在塑造脱髮症治疗药物市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解脱髮症治疗药物市场的竞争状况

对脱髮症治疗药物市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵脱髮症治疗市场供应商的绩效评估

FPNV 定位矩阵是评估脱髮症治疗药物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，描绘脱髮症治疗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，脱髮症治疗药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 脱髮症和脱髮症的发生率增加
      • 人们对脱髮症和移植的认识不断提高
      • 收入水准上升和医疗费用上升
    • 抑制因素
      • 脱髮症治疗缺乏报销政策
    • 机会
      • 脱髮症新治疗方法和药物的出现
      • 增加毛髮移植诊所的投资和扩张
    • 任务
      • 有关某些脱髮治疗疗法的功效和副作用的问题
  • 市场区隔分析
    • 疾病类型：对脱髮症和全脱髮症的有效治疗方法的需求日益增长。
    • 最终使用者：方便且经济高效的居家照护治疗
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章脱髮症治疗药物市场：依疾病类型

  • 脱髮症
  • 全脱髮症
  • 全身性脱髮症
  • 雄性脱髮症
  • 疤痕脱髮症
  • 牵引性脱髮症

第七章脱髮症治疗药物市场：依给药途径

  • 可注射的
  • 口服
  • 话题

第八章脱髮症治疗药物市场性别

  • 女士
  • 男人

第九章按治疗方案分類的脱髮症治疗药物市场

  • 美容治疗
    • 头髮纤维粉
    • 头皮微色素沉着
  • 治疗
    • 蒽甙
    • 皮质类固醇
    • JAK抑制剂
    • 胺基甲基叶酸
    • 局部免疫治疗
  • 手术治疗
    • 毛囊单位提取
    • 毛髮移植手术
    • 头皮缩小治疗

第10章脱髮症治疗药物市场：依最终用户分类

  • 皮肤科诊所
  • 居家照护环境

第十一章 北美和南美脱髮症治疗药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太地区脱髮症治疗药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的脱髮症治疗药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 礼来公司的Olumiant（Baricitinib ）在加拿大核准用于治疗严重脱髮症
    • HopeMed 推进创新雄性激素基因疗法治疗脱髮症的 2 期临床试验
    • FDA核准辉瑞 LITFULO（ritrecitinib）用于治疗重症患者脱髮症
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Aclaris Therapeutics, Inc.
  • AnaptysBio Inc.
  • Apira Science, Inc.
  • Apple Therapeutics Private Limited
  • Arcutis Biotherapeutics, Inc.
  • Biocon Limited
  • Cipla, Inc.
  • Daiichi Sankyo Inc.
  • DR. KURT WOLFF GMBH & CO. KG
  • Dr. Reddy's Laboratories Ltd
  • Eli Lilly and Company
  • Fagron NV
  • Follica, Inc.
  • HCell Inc.
  • iRestore Hair Growth System
  • KNOW Bio LLC
  • Merck & Co.
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • RepliCel Life Sciences Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Transitions Hair Pty Ltd.
  • Viviscal
Product Code: MRR-A339DAEFA47E

The Alopecia Treatment Market was valued at USD 4.85 billion in 2023, expected to reach USD 5.27 billion in 2024, and is projected to grow at a CAGR of 8.89%, to USD 8.81 billion by 2030.

The scope and definition of the alopecia treatment market encompass therapeutic interventions and products aimed at counteracting hair loss associated with conditions like alopecia areata, androgenetic alopecia, and other scalp disorders. The necessity for such treatments is underscored by the psychological impact of hair loss, which can significantly affect a person's quality of life and self-esteem. Applications include topical treatments, oral medications, surgical procedures like hair transplantation, and emerging therapies such as platelet-rich plasma and laser treatments. End-use segments primarily involve dermatology clinics, aesthetic centers, and individual home users. Key growth factors include rising awareness about alopecia treatments, advancements in treatment technologies, and increased healthcare expenditure. Notably, the advent of biologics and increased R&D in gene therapy present fresh opportunities for market players. Potential opportunities lie in personalized medicine approaches and expanding access in emerging markets through affordable solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 4.85 billion
Estimated Year [2024] USD 5.27 billion
Forecast Year [2030] USD 8.81 billion
CAGR (%) 8.89%

However, the market faces several limitations and challenges, including high treatment costs, variability in patient response, potential side effects, and regulatory hurdles. Additionally, cultural perceptions and stigmas associated with aesthetic treatments might impede growth in certain regions. To navigate these challenges and foster growth, innovation and research could focus on developing safer, more effective treatments with fewer side effects, such as peptide-based interventions and novel delivery mechanisms like nanotherapy. Cutting-edge research in understanding the genetic basis of hair disorders could further tailor treatment options. The alopecia treatment market is dynamic, characterized by competitive pressures and rapid technological advancements, suggesting a need for continuous innovation. Companies may gain a competitive edge by investing in collaborations and fostering strategic partnerships with research institutions and health care providers, thereby enhancing their R&D capabilities and expanding their product portfolios.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Alopecia Treatment Market

The Alopecia Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of androgenetic alopecia and alopecia areata diseases
    • Growing awareness about hair loss and transplantation
    • Rise in income levels and increased healthcare spending
  • Market Restraints
    • Lack of reimbursement policies for alopecia treatments
  • Market Opportunities
    • Emergence of new alopecia areata treatments and therapeutics
    • Rising investments and expansion of hair transplant clinics
  • Market Challenges
    • Issues associated with efficacy and side-effects related to some hair loss treatment therapies

Porter's Five Forces: A Strategic Tool for Navigating the Alopecia Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Alopecia Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Alopecia Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Alopecia Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Alopecia Treatment Market

A detailed market share analysis in the Alopecia Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Alopecia Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Alopecia Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Alopecia Treatment Market

A strategic analysis of the Alopecia Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Alopecia Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aclaris Therapeutics, Inc., AnaptysBio Inc., Apira Science, Inc., Apple Therapeutics Private Limited, Arcutis Biotherapeutics, Inc., Biocon Limited, Cipla, Inc., Daiichi Sankyo Inc., DR. KURT WOLFF GMBH & CO. KG, Dr. Reddy's Laboratories Ltd, Eli Lilly and Company, Fagron NV, Follica, Inc., HCell Inc., iRestore Hair Growth System, KNOW Bio LLC, Merck & Co., Pfizer Inc., Regeneron Pharmaceuticals, Inc., RepliCel Life Sciences Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Transitions Hair Pty Ltd., and Viviscal.

Market Segmentation & Coverage

This research report categorizes the Alopecia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Type, market is studied across Alopecia Areata, Alopecia Totalis, Alopecia Universalis, Androgenetic Alopecia, Cicatricial Alopecia, and Traction Alopecia.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Gender, market is studied across Female and Male.
  • Based on Treatment Option, market is studied across Cosmetic Treatment, Medical Treatment, and Surgical Treatment. The Cosmetic Treatment is further studied across Hair Fiber Powders and Scalp Micropigmentation. The Medical Treatment is further studied across Anthralin, Corticosteroid, JAK Inhibitors, Methotrexate, and Topical Immunotherapy. The Surgical Treatment is further studied across Follicular Unit Extraction, Hair Transplant Surgery, and Scalp Reduction Treatment.
  • Based on End User, market is studied across Dermatology Clinics and Homecare Setting.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of androgenetic alopecia and alopecia areata diseases
      • 5.1.1.2. Growing awareness about hair loss and transplantation
      • 5.1.1.3. Rise in income levels and increased healthcare spending
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement policies for alopecia treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of new alopecia areata treatments and therapeutics
      • 5.1.3.2. Rising investments and expansion of hair transplant clinics
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with efficacy and side-effects related to some hair loss treatment therapies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Disease Type: Growing need for effective treatments for alopecia universalis and alopecia totalis
    • 5.2.2. End User: homecare treatments owing to their Convenience and cost-effectiveness
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Alopecia Treatment Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Alopecia Areata
  • 6.3. Alopecia Totalis
  • 6.4. Alopecia Universalis
  • 6.5. Androgenetic Alopecia
  • 6.6. Cicatricial Alopecia
  • 6.7. Traction Alopecia

7. Alopecia Treatment Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Alopecia Treatment Market, by Gender

  • 8.1. Introduction
  • 8.2. Female
  • 8.3. Male

9. Alopecia Treatment Market, by Treatment Option

  • 9.1. Introduction
  • 9.2. Cosmetic Treatment
    • 9.2.1. Hair Fiber Powders
    • 9.2.2. Scalp Micropigmentation
  • 9.3. Medical Treatment
    • 9.3.1. Anthralin
    • 9.3.2. Corticosteroid
    • 9.3.3. JAK Inhibitors
    • 9.3.4. Methotrexate
    • 9.3.5. Topical Immunotherapy
  • 9.4. Surgical Treatment
    • 9.4.1. Follicular Unit Extraction
    • 9.4.2. Hair Transplant Surgery
    • 9.4.3. Scalp Reduction Treatment

10. Alopecia Treatment Market, by End User

  • 10.1. Introduction
  • 10.2. Dermatology Clinics
  • 10.3. Homecare Setting

11. Americas Alopecia Treatment Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Alopecia Treatment Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Alopecia Treatment Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Lilly's Olumiant (Baricitinib) Authorized in Canada for Severe Alopecia Areata Treatment
    • 14.3.2. HopeMed Advances Phase II Clinical Trials for Innovative Androgenetic Alopecia Treatment
    • 14.3.3. FDA Approves Pfizer's LITFULO (Ritlecitinib) for Severe Alopecia Treatment
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aclaris Therapeutics, Inc.
  • 3. AnaptysBio Inc.
  • 4. Apira Science, Inc.
  • 5. Apple Therapeutics Private Limited
  • 6. Arcutis Biotherapeutics, Inc.
  • 7. Biocon Limited
  • 8. Cipla, Inc.
  • 9. Daiichi Sankyo Inc.
  • 10. DR. KURT WOLFF GMBH & CO. KG
  • 11. Dr. Reddy's Laboratories Ltd
  • 12. Eli Lilly and Company
  • 13. Fagron NV
  • 14. Follica, Inc.
  • 15. HCell Inc.
  • 16. iRestore Hair Growth System
  • 17. KNOW Bio LLC
  • 18. Merck & Co.
  • 19. Pfizer Inc.
  • 20. Regeneron Pharmaceuticals, Inc.
  • 21. RepliCel Life Sciences Inc.
  • 22. Sun Pharmaceutical Industries Ltd.
  • 23. Teva Pharmaceutical Industries Ltd
  • 24. Transitions Hair Pty Ltd.
  • 25. Viviscal

LIST OF FIGURES

  • FIGURE 1. ALOPECIA TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. ALOPECIA TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ALOPECIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. ALOPECIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALOPECIA TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALOPECIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALOPECIA TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA AREATA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA TOTALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ALOPECIA UNIVERSALIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANDROGENETIC ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CICATRICIAL ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TRACTION ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR FIBER POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP MICROPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY ANTHRALIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY JAK INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY METHOTREXATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY TOPICAL IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY FOLLICULAR UNIT EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HAIR TRANSPLANT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SCALP REDUCTION TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL ALOPECIA TREATMENT MARKET SIZE, BY HOMECARE SETTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES ALOPECIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 205. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. ITALY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. ITALY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 269. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 277. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 285. POLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. POLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. QATAR ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. QATAR ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 301. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 317. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 325. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 333. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY TREATMENT OPTION, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY COSMETIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY MEDICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN ALOPECIA TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 341. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 342. SWITZERLAND ALOPECIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)

TABLE